EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Day

June 17, 2025

Unexpected Research Pivot Leads Seed Grant Recipient to New Gastric Cancer Targets

When Dr. Ryan Moy first received a $100,000 seed grant from Gastric Cancer Foundation in 2023, his goal was to investigate the...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 338
Millbrae, CA 94030

For Deliveries:
Gastric Cancer Foundation
501 Broadway, #338
Millbrae, CA 94030-1907

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

2 hours ago

New guidance from the American Gastroenterological Association (AGA) suggests that endoscopic screening and surveillance of precancerous conditions in people who face a high risk of gastric cancer could reduce incidence and mortality. ... See MoreSee Less

Gastric Cancer Prevention: New AGA Update Reflects Latest High-Risk Screening and Surveillance Advice | MDedge

www.mdedge.com

Gastric cancer remains a leading cause of preventable cancer and mortality in certain US populations

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 days ago

A new combination therapy incorporating Keytruda (pembrolizumab) into treatment for HER2-positive gastric cancer was recently approved. Memorial Sloan Kettering Cancer Center oncologist Yelena Janjigian discusses how to manage side effects. Via Targeted Oncology. ... See MoreSee Less

Managing Adverse Events in Pembrolizumab Therapy for Gastric Cancer

www.targetedonc.com

Yelena Y. Janjigian, MD, discusses how to manage the potential adverse events of pembrolizumab when using the recently approved combination of pembrolizumab plus trastuzumab and chemotherapy.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Adding the immune-boosting drug Tecentriq (atezolizumab) to Herceptin (trastuzumab) plus chemotherapy showed promise in a trial in patients with ERBB2–positive gastric cancer. Via Cancer Network. ... See MoreSee Less

Atezolizumab/Trastuzumab Plus Chemotherapy Shows Efficacy in Gastric Cancer

www.cancernetwork.com

Pathological complete response was higher among patients with ERBB2–positive gastric cancer or GEJ adenocarcinoma treated with atezolizumab vs without.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 weeks ago

The detection of gastric cancer in its earliest stages, when the probability of treatment success is highest, has increased by more than 50% in the last 20 years. Here’s more on this positive trend, via Healio. ... See MoreSee Less

Gastric cancer is increasingly diagnosed at early, more treatable stages

www.healio.com

SAN DIEGO — Detection of early-stage gastric cancer has become more common over the past 2 decades, while diagnosis of advanced-stage disease has been steadily declining, according to data presented...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 weeks ago

GI Cancers Alliance & Test Your Biomarkers recently partnered with OncLive for a series of videos on the latest updates in gastric cancer biomarker and drug development. Watch the series with Dr. Sunnie Kim at the link. ... See MoreSee Less

www.facebook.com

www.facebook.com

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X